Master Degree in Pharmaceutical Sciences (Pharmacology)

Program Description

This specialized Master’s program centers on advanced pharmacology and translational immunology. The curriculum emphasizes the mechanistic elucidation and modulation of fundamental molecular and cellular immune pathways, leveraging them as critical pharmacological targets. The primary objective is the rational design and preclinical development of novel immunotherapies aimed at managing complex human pathologies, including malignancy, chronic inflammatory conditions, and inflammatory neurodegenerative disorders. The program strategically addresses the immediate regional deficit in specialized scientific human capital equipped to drive immunotherapeutic innovation within the Middle East and North Africa (MENA) healthcare sector.

Learning Outcomes

• Upon successful completion of the program, graduates will demonstrate sophisticated mastery across four core domains. In Fundamental Knowledge, they will synthesize advanced molecular and cellular pharmacology principles, integrate comprehensive immunology (including immune-mediated disease and tolerance), critically analyze principles of immunopharmacology (drug-immune interactions), and evaluate applications of pharmacogenomics and bioinformatics for personalized medicine and target identification. Within the domain of Research Competence (Pharmaceutical Care), graduates will be able to formulate rigorous research questions and hypotheses, design robust experimental strategies using advanced molecular and cellular methodologies, proficiently execute advanced laboratory and computational techniques, and critically analyze and interpret complex experimental data to draw valid conclusions. Pertaining to Professional and Ethical Practice, they will effectively communicate complex research findings to diverse audiences, adhere strictly to the principles of responsible conduct of research and intellectual property guidelines, collaborate effectively within multidisciplinary teams, and critically evaluate the ethical and societal implications of novel immunotherapeutic interventions. Finally, in Personal Practice, they will continually evaluate and synthesize primary scientific literature, demonstrate independent initiative and effective project management, engage in continuous professional development to adapt to emerging technologies, and effectively translate and disseminate research findings through public presentation and thesis defense.